Science Corporation implants its vision-restoring chip in its first Stargardt disease patient

Science Corporation has implanted its vision-restoring chip in its first Stargardt disease patient. Max Hodak, the former president and co-founder of Neuralink, stated at TechCrunch Disrupt that the company's work with PRIMA is part of its path toward a novel brain-computer interface.